company tower banner
Greentech Company Logo
HAIRILINE® is a natural active ingredient against hair-loss (alopecia). It provides a protection of hair health by acting on scalp microbiota. It is the first active ingredient inducing the restoration of an healthy mycobiota and bacteriodata and acting on key cellular pathways (Wnt/beta-catenin), resulting in hair-growth. This is also allowed thanks to terpenes. It is anti-hair loss & scalp microbiota modulator.

INCI Name: Lindera Strychnifolia Root Extract

Functions: Anti-Hair Loss Agent

Ingredient Origin: Natural Origin

Labeling Claims: Allergen-free, BSE-free, CMR Substances-free, EDTA-free, GMO-free, Gluten-free, Glycol ether-free, Halal, Impurities-free, Microplastics-free, Nanomaterials-free, Natural, Nitrosamines-free, Non-Irritant, Non-Mutagenic, Non-Phototoxic, Non-Toxic, Not Tested on Animals, Phthalates-free, Preservative-free, Solvent-free, Sustainable, TSE-free, Ulta Beauty's Conscious Beauty, VOC-free, Vegan

Benefit Claims: Compatibility, Improves Hair Thickness, Increases Hair Density, Nutritional Balance, Prevents Hair Loss, Restoring, Scalp Protection Effect

Certifications & Compliance: CFDA Compliant (China), COSMOS, EU Cosmetic Regulation 1223/2009 Compliant, FDA Compliant, GMP, Halal, IECIC (China), ISO 16128, ISO 22716, RSPO MassBalance Certified

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Ingredient Origin
Cosmetic Ingredients Functions
EINECS No.
231-791-2, 207-997-3
Origin
  • Propanediol - Vegetable
  • Aqua - Mineral
  • Lindera Strychnifolia Root Extract - Vegetable

Features & Benefits

Product Background

HAIR ISSUE STUDIED BY GREENTECH

Hair loss, or alopecia, is a common disorder that affects people of all ages. It is characterized by the formation of very fine vellus hairs resulting from the miniaturization of the hair follicles, thereby leading to the appearance of baldness. The most common type (90%) is androgenetic alopecia. It concerns 28% of males between 18-29 years old and 53% of males after 40 years old. The pathophysiology of alopecia is multifactorial, including stress, nutrition, exposome, genetic predisposition, hormonal sensibility.

Microbiota also seems to play a key role in hair growth disorders. Finding balance both in bacteriobiota and mycobiota of the hair would then be a major step towards healthy hair.

Currently, only two Food and Drug Administration (FDA)-approved hair growth-promoting drugs, namely Minoxidil and Finasteride, are available in the market. However, these drugs are of limited use, because of their side effects.

Aware of the adverse effects of current therapies and being at the forefront of innovation in terms of microbiota, Greentech designed a natural alternative strategy using a systemic approach.

 

Actions

  • Rebalances Bacteriobiota & Mycobiota
  • Slows - Hair Loss
  • Restored Hair Vitality & Density
  • Improves WNT/ β-CATENIN Pathways

Molecules

  • SESQUITERPENES : LINDERANE (0.5-2.0 %) & LINDERALACTONE (1.5-3.0 %)
  • POLYPHENOLS (including Catechins & Tannins) : 20-35 % 

Sourcing

Lindera Strychnifolia Roots Native from South East of Asia
« A Promoter of Longevity and an Elixir of Life »

Applications & Uses

Hair Care Applications
Cosmetic Use
  • Scalp Microbiota Health
  • Anti-Hair Loss Products
  • Anti-Aging Hair Care
  • Daily Hair Care
Formulations
  • Concentration for use: 1-2%
  • pH for use: 4.0 - 6.0
  • Caution for use: Add in formulations at 35-40°C, while cooling or at any time in cold preparation.

Properties

Physical Form
Odor
Characteristic
Appearance
Liquid
Soluble in
Water, Propanediol
Insoluble in
10% in water
Typical Properties
ValueUnitsTest Method / Conditions
Natural Content15%-
Natural Origin concentration100%-
Physico-Chemical Properties
ValueUnitsTest Method / Conditions
Refraction Index1.420 - 1.460-GT007
Specific Gravity1.020 - 1.080-GT008
Quantifications
ValueUnitsTest Method / Conditions
Water Contentmax. 10.0%GT022
Microbiological Values
ValueUnitsTest Method / Conditions
Detection of EnterobacteriaAbsence-ISO 18415
Enumeration of Mesophilic Aerobic Bacteriamax. 100ufc/mL - cfu/mLISO 21149
Enumeration of Yeasts and Moldsmax. 100ufc/mL - cfu/mLISO 16212

Regulatory & Compliance

REACH Status
INCI Concentration REACH Status
Propanediol 85 – 93 % Propanediol registered
n°01-2119489383-28
Aqua ≤ 10 % Water exempted annex IV
Lindera Strychnifolia Root
Extract
5 – 7 % Exempt: < 1 ton/year (dry matter)

 

Technical Details & Test Data

Hair Follicle Growth Cycling And Hair Growth Pathways

The aim of our investigation is to normalize the Wnt signaling pathway, which plays a major role in the regeneration of hair follicle cells by acting on inhibitory proteins such as DKK-1, DKK-3 and sFRP-1.

Hairiline® - Hair Follicle Growth Cycling And Hair Growth Pathways

  • DKK : Dickkopf-Related Protein
  • TGFß: Transforming Growth Factor Beta
  • sFRP: Secreted Frizzled-Related Protein

Regeneration of the follicle is realized from a reservoir of stem cells that proliferate and differentiate under the effect of signaling pathways (Wnt/β-catenin). DKK-1 blocks the initiation of this phase, TGFβ improves Catagen phase and sFRP-1 blocks Wnt activation. 

Clinical Study - In Vivo
  • HAIRILINE® IMPROVES HAIR NUMBER

Hairiline® - Clinical Study - in Vivo

 

  • HAIRILINE® IMPROVES HAIR NUMBER AFTER 84 DAYS 

One solution proposed against chronic alopecia is hair transplantation. Between 3000 and 5000 hairs are then transplanted. 

With HAIRILINE® :

HAIRILINE® + 7% ~ + 7000 Hairs

 

  • SELF-ASSESSMENT
  % of men reporting
A SPEED UP OF THE GROWTH 81%
A DECREASE OF HAIR IN BRUSH, ON CLOTHES AND PILLOWS 73%
A STIMULATION OF HAIR GROWTH AND A SLOW DOWN OF FALL 77%
A DENSIFICATION OF HAIR 81%

 

Hairiline® - Clinical Study - in Vivo - 1

Evaluation of hairiline® about hair properties

Hairiline® reduces hair loss and improves quality of hair

 

  • CHARACTERIZATION OF ALOPECIA SCALP MICROBIOME

We first characterized the alopecia microbiota and secondly evaluate the effect of HAIRILINE®. 

Simple blind test on 24 men (12 healthy & 12 type II & III Alopecia). Men age 49 years old. HAIRILINE® 1% versus placebo.
Twice daily application during 84 days. Measurements : 16S ribosomal RNA for bacteria & ITS1 (Internal Transcripted Spacer 1) DNA for fungi

CHARACTERIZATION OF ANDROGENETIC ALOPECIA BACTERIOBIOTA (at Day 0)

Hairiline® - Clinical Study - in Vivo - 2

At Phylum & Genus levels

  • Comparable repartition between healthy and androgenic alopecia scalps (in agreement with Polak-Witka et al., 2019)

At Species level

  • Lower mean reads of Staphylococcus epidermidis (p<0.05)
  • Higher mean reads of : Cutibacterium acnes and Stenotrophomonas sp (p<0.05) in alopecia as compared to control, inducing microinflammation, keratinase secretion and therefore hair-loss. 

CHARACTERIZATION OF ANDROGENETIC ALOPECIA MYCOBIOTA (at Day 0)

At Phylum level

  • Lower abundance of Basidiomycota and higher abundance of Ascomycota as compared to control

At Species level

  • Decrease of Malassezia globosa/Malassezia restricta ratio as compared to control.

At Genus level 

  • Lower proportion of Malassezia genus and increase of other bacterial genus inducing keratinase synthesis ans therefore acceleration of hair-loss.

EFFECT OF HAIRILINE® ON THE SCALP MICROBIOME

WITH HAIRILINE® (at D84) (BACTERIOBIOTA)

At Phylum & Genus levels

Hairiline® maintains bacterial diversity

RATIO C. ACNES / S. EPIDERMIDIS

Hairiline® - Clinical Study - in Vivo - 3

 

At Species level

NUMBER OF STENOTROPHOMONAS

Hairiline® - Clinical Study - in Vivo - 4

 

HAIRILINE® decreases the ratio of Cutibacterium acnes/Staphylococcus epidermidis
involved in androgenic pathogenesis . A decrease of Stenotrophomonas geniculata
was also observed.

Hairiline® rebalances the bacteriobiota ratio of the scalp, linked to healthy scalp.

 

WITH HAIRILINE® (at D84) (MYCOBIOTA)

At Species level

RATIO M. GLOBOSA / M. RESTRICTA

Hairiline® - Clinical Study - in Vivo - 5

HAIRILINE® rebalances the M. restrica/M. globosa ratio.

Hairiline® restores the scalp mycoecology.

Proven Efficacy - In Vitro Test

HAIRILINE® MODULATES INHIBITORS OF THE MAIN SIGNALING PATHWAYS
FOR HAIR GROWTH

Dickkopf related protein-1 (DKK-1) is a protein and a potent antagonist of the Wnt signaling pathway. It induces keratinocytes apoptosis and catagen phase and is overexpressed in alopecia.

Dermal fibroblast cells from a healthy donor (54 years old). Treatment during 48h with HAIRILINE® at several concentrations. Protein quantification in the supernatant by ELISA. *** p<0.001 vs control.

Hairiline® - Proven Efficacy - in Vitro TestDKK-1 (PG.μG OF PROTEINS-1)

Hairiline® inhibits the secretion of the catagen inducer, dkk-1, limiting hair loss

 

Hair loss is the result of premature entry into catagen due to various causes: TGFβ-1 (Transforming Growth Factor 1) is a catagen inducer.

Dermal papilla cells from a healthy donor (76 years old).
Treatment during 24h with HAIRILINE® at several concentrations. Protein quantification in the supernatant by ELISA. ** p<0.01, *** p<0.001 vs control

Hairiline® - Proven Efficacy - in Vitro Test - 1

TGFB-1 SECRETION (RELATIVE QUANTIFICATION)

 

  • HAIRILINE® DECREASES VASOCONSTRICTION FACTOR RELEASE

Endothelin-1 (EDT-1) is a potent vasoconstrictor. It induces the regression of Anagen hair follicle.

Dermal microvascular endothelial cells from a healthy donor (30 years old).
Treatment during 24h with HAIRILINE® at several concentrations.
Protein quantification in the supernatant by ELISA. * p<0.05 vs control. 

  VS CONTROL
ENDOTHELIN-1 SECRETION (At 0.02%) -21%*

Hairiline® reduces endothelin-1 secretion, improving blood supply to hair.

 

sFRP-1 protein is an inhibitor of Wnt signaling pathways, inducing hair-loss.

  VS CONTROL
sFRP-1 (At 0.2%) -21%*

Hairiline® limits the secretion of tgfβ-1 & production of the wnt antagonist sfrp-1, reducing hair loss.

 

  • HAIRILINE® IS BETTER THAN MINOXIDIL CONCERNING PAPILLA CELLS PROLIFERATION

Hairiline® - Proven Efficacy - in Vitro Test - 2

Human follicle Dermal papilla cells (HFDPC).
Treatment during 48H with HAIRILINE® or MINOXIDIL at several concentrations.
Cell proliferation was evaluated by MTT method.
** p<0.01, **** p<0.001, vs control.

Hairiline® has inhibitory effects on dkk-1 and tgfβ-1 secretion follicle dermal papilla cells: not found with minoxidil.

Safety & Health

Toxicological Tests
Tests Method Tested Concentrat Results
Skin Irritation Patch Test 1 % Not irritant
Eye Irritation Het cam 1 % Pratically non irritant
Sensitization HRIPT 1 % Very good skin compatibility
Phototoxicity ISO
24442:2011
1 % Not phototoxic
Mutagenicity test Ames test Product tested at 8
dilutions
Not mutagenic

 

Storage & Handling

Shelf Life
24 months
Storage

15 / +25°C
Keep in the original packaging, without opening, in the recommended storage conditions.
Advice before use : Agitation